ERBB2 and breast cancer: Indeed, ITGB1 and ITGB3 have been reported to play an important role in HER-2-induced mammary tumor growth and metastasis to the lungs, and this is associated with the promotion of signaling through the insulin receptor-AKT-mTORC1 pathway [29].